Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer
Ross Harrison, Shuangshuang Fu, Charlotte C. Sun, Hui Zhao, Karen H. Lu, Sharon H. Giordano, Larissa A. Meyer
Topics & Concepts
MedicinePolymeraseOlaparibInterquartile rangePoly ADP ribose polymeraseReimbursementPARP inhibitorAdenosine diphosphateInternal medicinePharmacologyHealth careBiochemistryEnzymeChemistryPlateletEconomic growthPlatelet aggregationEconomicsPARP inhibition in cancer therapyEconomic and Financial Impacts of CancerMedication Adherence and Compliance